NASDAQ:CLSD
Clearside BioMedical, Inc Stock News
$1.33
+0.0200 (+1.53%)
At Close: May 20, 2024
Clearside Biomedical (CLSD) Gets a Hold Rating from Needham
09:43am, Thursday, 12'th Mar 2020
In a report released today, Serge Belanger from Needham maintained a Hold rating on Clearside Biomedical (CLSD). The company's shares closed last Monday
Clearside Biomedical (CLSD) Gets a Hold Rating from Needham
09:43am, Thursday, 12'th Mar 2020
In a report released today, Serge Belanger from Needham maintained a Hold rating on Clearside Biomedical (CLSD – Research Report).
Edited Transcript of CLSD earnings conference call or presentation 11-Mar-20 8:30pm GMT
07:00am, Thursday, 12'th Mar 2020
Q4 2019 Clearside Biomedical Inc Earnings Call
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12:00am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
5 Stocks Moving In Wednesday's After-Hours Session
08:48pm, Wednesday, 11'th Mar 2020
Gainers
Clearside Biomedical (NASDAQ: CLSD) shares are trading higher after the company announced a license agreement with Arctic Vision. The company also reported better-...
Clearside Biomedical Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
08:05pm, Wednesday, 11'th Mar 2020
- IND Submission for CLS-AX (axitinib injectable suspension) On Track for Mid-2020 -- Greater China Licensing Partnership and Updated NDA Resubmission Timeline for XIPERE™.
Clearside Biomedical Appoints Dr. George Lasezkay as President and Chief Executive Officer
08:04pm, Wednesday, 11'th Mar 2020
Clearside Biomedical, Inc. (CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, ann
Clearside Biomedical, Inc. (CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, ann
Clearside Biomedical, Inc. to Host Earnings Call
06:30pm, Wednesday, 11'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 11, 2020 / Clearside Biomedical, Inc. (NASDAQ:CLSD) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 11, 2020
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
08:14pm, Sunday, 08'th Mar 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.The week was light on news flow, barring some smid-cap earnings and COVID-19 treatment and vaccin
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
12:00am, Sunday, 08'th Mar 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.
The week was light on news flow, barring some smid-cap earnings and...
Clearside Biomedical, Inc. (CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, ann
Clearside Biomedical to Present at Two Upcoming Investor Conferences in March 2020
12:05pm, Wednesday, 26'th Feb 2020
ALPHARETTA, Ga., Feb. 26, 2020 -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and.
Clearside Biomedical Pipeline Highlighted in Oral Presentations at the Annual Angiogenesis and Macula Society Meetings
12:05pm, Tuesday, 25'th Feb 2020
Clearside Biomedical, Inc. (CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, ann
Clearside Biomedical Announces Presentations to be Given at Angiogenesis and Macula Society Conferences
12:05pm, Wednesday, 05'th Feb 2020
ALPHARETTA, Ga., Feb. 05, 2020 -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and.
